| HOME >> MEDICINE >> TECHNOLOGY |
SANFORD, Fla., Sept. 12, 2011 /PRNewswire/ -- .decimal, Inc. (pronounced dot decimal), an innovative manufacturer of patient-specific medical devices for radiation therapy, announced that it received 510(k) clearance from the FDA to market electron apertures for use with Varian treatment machines. These devices are now available to radiation oncology centers across the U.S. and Canada.
Electron apertures -- also known as electron 'cutouts' by radiation therapy departments -- are medical devices required for the targeted delivery of electrons to patients in radiation therapy.
As a medical device, an electron aperture is a metal tool featuring an opening through which a radiation beam passes during the delivery of electrons to a patient with a tumor, as in the case of neck and head or breast cancer.
Hospitals and cancer centers across the U.S. will order electron apertures via the internet and receive the devices already in the mold frames within 24 to 72 hours from receipt of an order.
By providing custom-made electron apertures to radiation oncology centers, .decimal® helps these facilities reduce the cost of maintaining an on-site mold room, which can add to the department or facility's costs.
"At .decimal®, our staff excels at the development of radiation therapy devices based on our customers' needs," said Richard Sweat, President and CEO of .decimal, Inc. "We are energized that the release of Electron Apertures can eliminate the need to handle toxic materials like Cerrobend at medical facilities."
Cerrobend is an alloy composed of cadmium, lead and tin which can be shaped at relatively low temperatures, but releases toxic fumes that, when produced at a medical facility, have the potential for affecting clinical personnel thus requiring expensive ventilation systems.
With this solution, .decimal® provides radiation therapy facilities the ability to focus on treating pa
'/>"/>
| SOURCE .decimal, Inc. Copyright©2010 PR Newswire. All rights reserved |